Inlita

Were you looking for more information about Inlyta? Inlita is a common misspelling of Inlyta.
 
A healthcare provider may prescribe Inlyta® (axitinib) to help slow down the progression of advanced renal cell carcinoma, a type of kidney cancer. This medication is specifically approved for use in adults who have tried at least one other type of kidney cancer medication, but without success.
 
To help ensure a safe treatment process, make sure to tell your healthcare provider about any other medical problems you might have, such as a history of blood clots or thyroid problems, as well as any other medications, vitamins, or supplements you are taking. Side effects of this drug may include fatigue, diarrhea, and nausea.
 
(Click Inlyta for more information, including other side effects to look out for during treatment and details on dosing instructions. You can also click any of the links in the box to the right for specific information.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.